EPR: Form 144 lists resale by Tonya Mater

EPR submitted a Form 144 disclosing proposed sales of Common shares by an affiliate.

Rhea-AI Filing Summary

EPR submitted a Form 144 disclosing proposed sales of Common shares by an affiliate. The form names Tonya Mater and lists two deferred‑compensation tranches dated 01/01/2018 (2,500 shares) and 01/01/2024 (4,984 shares). The filing shows CUSIP 765520011 and a filing/receipt date of 04/14/2026.

Insights

Securities Compliance Lawyer

Form 144 notifies potential resale under Rule 144 by a named affiliate.

Form 144 is a notice of proposed sale that permits restricted or control securities to be sold in reliance on Rule 144 once statutory conditions are met. The filing lists the seller as Tonya Mater and identifies the securities as deferred compensation shares.

Timing and actual transaction details are not provided here; subsequent Form 4 or broker records would show executed sales or placements.

Key Figures

Form receipt date: 04/14/2026 CUSIP: 765520011 Tranche shares (2018): 2,500 shares +2 more

5 metrics

Form receipt date 04/14/2026 Form 144 filing/receipt date

CUSIP 765520011 Unique security identifier listed on the filing

Tranche shares (2018) 2,500 shares Deferred compensation dated 01/01/2018 assigned to Tonya Mater

Tranche shares (2024) 4,984 shares Deferred compensation dated 01/01/2024 assigned to Tonya Mater

Exchange NYSE Trading venue indicated on the Form 144

Key Terms

Rule 144, Deferred Compensation, CUSIP

3 terms

Rule 144 regulatory

"Form 144 (resale notice) used to effect public resales of restricted securities"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Deferred Compensation financial

"Deferred Compensation Common reported with grant dates and share counts"

Deferred compensation is pay that employees or executives have earned now but will receive at a later date, such as delayed bonuses, retirement benefits, or stock grants. It matters to investors because it creates future obligations and shapes incentives—like a promise to pay later that can affect a company’s reported profits, cash needs and potential stock dilution—so it helps signal how a business manages costs and retains key people.

CUSIP market

"CUSIP 765520011 listed next to issuer/security details"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does EPR's Form 144 disclose about Tonya Mater?

The Form 144 names Tonya Mater as the selling person and lists two deferred‑compensation tranches dated 01/01/2018 and 01/01/2024. The filing shows 2,500 and 4,984 shares respectively and CUSIP 765520011.

Does the Form 144 confirm the shares were sold for EPR (EPR)?

No, the Form 144 notifies of proposed resale; it does not confirm executed sales. The document lists proposed tranches and the filing date 04/14/2026, but transaction execution details are not included here.

What securities and identifiers are listed on the filing for EPR?

The filing identifies the security as Common stock, lists the trading venue as NYSE, and provides CUSIP 765520011. It references deferred compensation awards dated 01/01/2018 and 01/01/2024.

Will this Form 144 change EPR's share count or outstanding figures?

The Form 144 itself is a resale notice and does not alter shares outstanding. It lists proposed sale tranches of 2,500 and 4,984 shares; any change to outstanding shares would follow actual sales recorded in subsequent filings or market records.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 07:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001652937
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EPR Properties
SEC File Number
Address of Issuer	909 Walnut Street Suite 200 Kansas City MISSOURI 64106
Phone	816-472-1700
Name of Person for Whose Account the Securities are To Be Sold	Tonya Mater
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Accounting Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 4801 Main Street, Suite 600 Kansas City MO 64112	2000	111917.69	765520011	04/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2018	Deferred Compensation	Tonya Mater			2500	01/01/2018	Deferred Compensation
Common	01/01/2024	Deferred Compensation	Tonya Mater			4984	01/01/2024	Deferred Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	04/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Tonya Mater
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)